Clinical trial
Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
NCT02702271 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT02702271 |
|---|---|
| Title | Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology |
| Official title | Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology |
| Acronym | PINNACLE FLX |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Device |
| Interventions | WATCHMAN FLX |
| Enrollment | 458 |
| Start date | May 7, 2018 |
| Primary completion | Jan 28, 2020 |
| Completion | Mar 12, 2021 |
| First posted | Mar 8, 2016 |
| Last update posted | Jun 14, 2022 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: